Papa Salif Sow, Ph.D, M.D. Department of Infectious Diseases Fann Hospital
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of Pregabalin vs Placebo in the Treatment of Neuropathic Pain Associated with HIV Neuropathy
ACTG 5202: Shorter Time to Virologic Failure (VF) with Abacavir/lamivudine (ABC/3TC) than Tenofovir/Emtricitabine (TDF/FTC) as Part of Combination Therapy in Treatment-Naïve Subjects with Screening HIV RNA ³100,000 c/mL
Abacavir/Lamivudine (ABC/3TC) Shows Robust Virologic Responses in ART-Naïve Patients for Baseline (BL) Viral Loads (VL) of ³100,000c/mL and <100,000c/mL by Endpoint Used in ACTG5202